AMPHASTAR PHARMACEUTICALS INC. - COMMON STOCK
43.91
28-March-24 15:59:57
15 minutes delayed
Stocks
+0.39
+0.90%
Today's range
43.76 - 44.83
ISIN
N/A
Source
NASDAQ
-
Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
27 May 2021 06:00:00 By Nasdaq GlobeNewswire
-
07 May 2021 16:05:00 By Nasdaq GlobeNewswire
-
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021
06 May 2021 16:05:02 By Nasdaq GlobeNewswire
-
Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection
03 May 2021 06:00:00 By Nasdaq GlobeNewswire
-
29 Apr 2021 06:00:00 By Nasdaq GlobeNewswire
-
Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference
06 Apr 2021 16:05:00 By Nasdaq GlobeNewswire
-
Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection
29 Mar 2021 06:00:00 By Nasdaq GlobeNewswire
-
15 Mar 2021 16:05:01 By Nasdaq GlobeNewswire
-
08 Mar 2021 17:39:05 By Nasdaq GlobeNewswire
-
Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference
26 Feb 2021 06:01:00 By Nasdaq GlobeNewswire